{"id":"556595-6538","orgnr":"556595-6538","name":"Abliva AB","name_registered_on":"2020-05-27","legal_form":{"code":"AB","name":"Aktiebolag"},"status":"registered","registered_on":"2000-08-16","other_names":[{"name":"NeuroVive Pharmaceutical","kind":"secondary_name","registered_on":"2020-05-27","scope":"För den del av verksamheten som avser forsking, utveckling, försäljning och licensiering av läkemedel och därmed förenlig verksmhet."}],"business_description":"Bolaget skall direkt eller indirekt genom dotterbolag bedriva forsking, utveckling, försäljning och licensiering av läkemedel samt därmed förenlig verksamhet. Bolaget ska även kunna förvalta fast och lös egendom.","industries":[{"code":"72109","name":"Annan naturvetenskaplig och teknisk forskning och utveckling"}],"postal_address":{"city":"LUND","country":"SE","municipality":{"code":"1281","name":"Lund"},"county":{"code":"12","name":"Skåne län"}},"registered_office":{"municipality":{"code":"1281","name":"Lund"},"county":{"code":"12","name":"Skåne län"}},"activity_status":"active","employee_class":{"code":"2","name":"1-4 anställda"},"turnover_class":{"code":"9","name":"500 000 - 999 999 tkr","year":2025},"f_tax":"registered","vat":"registered","employer":"registered","registry_source":{"dataset":"bolagsverket_bulkfil","published_on":"2026-11-16"},"annual_reports":[{"from":"2023-01-01","to":"2023-12-31","framework":"IFRS","documents":{"annual_report":"/v1/documents/6a66f6f3-74e8-4608-aba1-ee663eac3112.xhtml","certificate":"/v1/documents/13ce503b-7327-4602-a591-2215a4100c89.xhtml"},"source":{"dataset":"arsredovisningar","file":"2024/23_2.zip"}},{"from":"2022-01-01","to":"2022-12-31","framework":"IFRS","documents":{"annual_report":"/v1/documents/c0aa6109-dca1-40cb-b7c6-b072b814fdfa.xhtml","certificate":"/v1/documents/656607d5-8625-448c-87c5-0669fdb8831c.xhtml"},"source":{"dataset":"arsredovisningar","file":"2023/23_2.zip"}},{"from":"2021-01-01","to":"2021-12-31","framework":"IFRS","documents":{},"source":{"dataset":"esef","file":"/5493005YV22OTMUHZ183/2021-12-31/ESEF/SE/0/5493005YV22OTMUHZ183-2021-12-31-sv.zip","url":"https://filings.xbrl.org/5493005YV22OTMUHZ183/2021-12-31/ESEF/SE/0/5493005YV22OTMUHZ183-2021-12-31-sv/reports/ixbrlviewer.html"}}],"latest_financials":{"from":"2023-01-01","to":"2023-12-31","scope":"group","currency":"SEK","net_sales":137000,"operating_profit":-96548000,"profit_after_financial_items":-95518000,"net_profit":-95509000,"total_assets":87499000,"equity":70718000,"long_term_liabilities":424000,"current_liabilities":16357000,"cash":57664000,"staff_costs":18785000,"net_sales_growth":3.419,"source":{"annual_report":"2023-12-31","document":"/v1/documents/6a66f6f3-74e8-4608-aba1-ee663eac3112.xhtml"},"anchors":{"cash":{"text":"57 664","prefix":"medel 21"},"current_liabilities":{"text":"16 357","prefix":"599"},"equity":{"text":"70 718","prefix":"Summa eget kapital"},"long_term_liabilities":{"text":"424","prefix":"534"},"net_sales":{"text":"137","suffix":"31"},"operating_profit":{"text":"96 548","prefix":"4 -"},"profit_after_financial_items":{"text":"95 518","prefix":"skatt -"},"staff_costs":{"text":"18 785","prefix":"10,11 -"},"total_assets":{"text":"87 499","prefix":"SUMMA TILLGÅNGAR"}}}}